Skip to main content
Top
Published in: Inflammation 3/2018

01-06-2018 | ORIGINAL ARTICLE

miR-140-5p/miR-149 Affects Chondrocyte Proliferation, Apoptosis, and Autophagy by Targeting FUT1 in Osteoarthritis

Authors: Zi Wang, Jialei Hu, Yue Pan, Yujia Shan, Liqun Jiang, Xia Qi, Li Jia

Published in: Inflammation | Issue 3/2018

Login to get access

Abstract

Osteoarthritis (OA), the most prevalent chronic and degenerative joint disease, is characterized by articular cartilage degradation and chondrocyte injury. Increased cell apoptosis and defective cell autophagy in chondrocytes are a feature of degenerative cartilage. MicroRNAs (miRNAs) have been identified as potential regulators of OA. This study aimed to determine the potential role of miR-140-5p and miR-149 in apoptosis, autophagy, and proliferation in human primary chondrocytes and investigate the underlying mechanism. We revealed the differential expressional profiles of miR-140-5p/149 and fucosyltransferase 1 (FUT1) in the articular cartilage tissues of OA patients and normal people and validated FUT1 was a direct target of miR-140-5p/149. The overexpression of miR-140-5p/149 inhibited apoptosis and promoted proliferation and autophagy of human primary chondrocytes via downregulating FUT1. On the contrary, the downregulation of miR-140-5p/149 inhibited chondrocyte proliferation and autophagy, whereas the effect was reversed by FUT1 knockdown. Taken together, our data suggested that miR-140-5p and miR-149 could mediate the development of OA, which was regulated by FUT1. miR-140-5p/miR-149/FUT1 axis might serve as a predictive biomarker and a potential therapeutic target in OA treatment.
Literature
1.
go back to reference Loeser, R.F., S.R. Goldring, C.R. Scanzello, and M.B. Goldring. 2012. Osteoarthritis: a disease of the joint as an organ. Arthritis and Rheumatism 64: 1697–1707.CrossRefPubMedPubMedCentral Loeser, R.F., S.R. Goldring, C.R. Scanzello, and M.B. Goldring. 2012. Osteoarthritis: a disease of the joint as an organ. Arthritis and Rheumatism 64: 1697–1707.CrossRefPubMedPubMedCentral
2.
go back to reference Burr, D.B., and M.A. Gallant. 2012. Bone remodelling in osteoarthritis. Nature Reviews Rheumatology 8: 665–673.CrossRefPubMed Burr, D.B., and M.A. Gallant. 2012. Bone remodelling in osteoarthritis. Nature Reviews Rheumatology 8: 665–673.CrossRefPubMed
3.
go back to reference Goldring, M.B., and S.R. Goldring. 2007. Osteoarthritis. Journal of Cellular Physiology 213: 626–634.CrossRefPubMed Goldring, M.B., and S.R. Goldring. 2007. Osteoarthritis. Journal of Cellular Physiology 213: 626–634.CrossRefPubMed
4.
go back to reference Blanco, F.J., R. Guitian, E. Vazquez-Martul, F.J. de Toro, and F. Galdo. 1998. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis and Rheumatism 41: 284–289.CrossRefPubMed Blanco, F.J., R. Guitian, E. Vazquez-Martul, F.J. de Toro, and F. Galdo. 1998. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis and Rheumatism 41: 284–289.CrossRefPubMed
5.
go back to reference Kim, H.A., Y.J. Lee, S.C. Seong, K.W. Choe, and Y.W. Song. 2000. Apoptotic chondrocyte death in human osteoarthritis. The Journal of Rheumatology 27: 455–462.PubMed Kim, H.A., Y.J. Lee, S.C. Seong, K.W. Choe, and Y.W. Song. 2000. Apoptotic chondrocyte death in human osteoarthritis. The Journal of Rheumatology 27: 455–462.PubMed
6.
go back to reference Yan, S., M. Wang, J. Zhao, H. Zhang, C. Zhou, L. Jin, Y. Zhang, X. Qiu, B. Ma, and Q. Fan. 2016. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis. International Journal of Molecular Medicine 38: 201–209.CrossRefPubMedPubMedCentral Yan, S., M. Wang, J. Zhao, H. Zhang, C. Zhou, L. Jin, Y. Zhang, X. Qiu, B. Ma, and Q. Fan. 2016. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis. International Journal of Molecular Medicine 38: 201–209.CrossRefPubMedPubMedCentral
7.
go back to reference Mizushima, N. 2009. Physiological functions of autophagy. Curr Top Microbiol 335: 71–84. Mizushima, N. 2009. Physiological functions of autophagy. Curr Top Microbiol 335: 71–84.
8.
go back to reference Rabinowitz, J.D., and E. White. 2010. Autophagy and metabolism. Science (New York, N.Y.) 330: 1344–1348.CrossRef Rabinowitz, J.D., and E. White. 2010. Autophagy and metabolism. Science (New York, N.Y.) 330: 1344–1348.CrossRef
9.
go back to reference Meckes, J.K., B. Carames, M. Olmer, W.B. Kiosses, S.P. Grogan, M.K. Lotz, and D.D. D'Lima. 2017. Compromised autophagy precedes meniscus degeneration and cartilage damage in mice. Osteoarthritis and Cartilage 25: 1880–1889.CrossRefPubMed Meckes, J.K., B. Carames, M. Olmer, W.B. Kiosses, S.P. Grogan, M.K. Lotz, and D.D. D'Lima. 2017. Compromised autophagy precedes meniscus degeneration and cartilage damage in mice. Osteoarthritis and Cartilage 25: 1880–1889.CrossRefPubMed
10.
go back to reference Carames, B., W.B. Kiosses, Y. Akasaki, D.C. Brinson, W. Eap, J. Koziol, and M.K. Lotz. 2013. Glucosamine activates autophagy in vitro and in vivo. Arthritis and Rheumatism 65: 1843–1852.CrossRefPubMedPubMedCentral Carames, B., W.B. Kiosses, Y. Akasaki, D.C. Brinson, W. Eap, J. Koziol, and M.K. Lotz. 2013. Glucosamine activates autophagy in vitro and in vivo. Arthritis and Rheumatism 65: 1843–1852.CrossRefPubMedPubMedCentral
11.
go back to reference Matsuzaki, T., T. Matsushita, Y. Tabata, T. Saito, T. Matsumoto, K. Nagai, R. Kuroda, and M. Kurosaka. 2014. Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model. Biomaterials 35: 9904–9911.CrossRefPubMed Matsuzaki, T., T. Matsushita, Y. Tabata, T. Saito, T. Matsumoto, K. Nagai, R. Kuroda, and M. Kurosaka. 2014. Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model. Biomaterials 35: 9904–9911.CrossRefPubMed
12.
13.
go back to reference He, L., and G.J. Hannon. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews. Genetics 5: 522–531.CrossRefPubMed He, L., and G.J. Hannon. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews. Genetics 5: 522–531.CrossRefPubMed
14.
15.
go back to reference Chen, C.Z., L. Li, H.F. Lodish, and D.P. Bartel. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science (New York, N.Y.) 303: 83–86.CrossRef Chen, C.Z., L. Li, H.F. Lodish, and D.P. Bartel. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science (New York, N.Y.) 303: 83–86.CrossRef
16.
go back to reference Wu, C., B. Tian, X. Qu, F. Liu, T. Tang, A. Qin, Z. Zhu, and K. Dai. 2014. MicroRNAs play a role in chondrogenesis and osteoarthritis (review). International Journal of Molecular Medicine 34: 13–23.CrossRefPubMed Wu, C., B. Tian, X. Qu, F. Liu, T. Tang, A. Qin, Z. Zhu, and K. Dai. 2014. MicroRNAs play a role in chondrogenesis and osteoarthritis (review). International Journal of Molecular Medicine 34: 13–23.CrossRefPubMed
17.
go back to reference Miyaki, S., T. Sato, A. Inoue, S. Otsuki, Y. Ito, S. Yokoyama, Y. Kato, F. Takemoto, T. Nakasa, S. Yamashita, et al. 2010. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes & Development 24: 1173–1185.CrossRef Miyaki, S., T. Sato, A. Inoue, S. Otsuki, Y. Ito, S. Yokoyama, Y. Kato, F. Takemoto, T. Nakasa, S. Yamashita, et al. 2010. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes & Development 24: 1173–1185.CrossRef
18.
go back to reference Santini, P., L. Politi, P.D. Vedova, R. Scandurra, and A. Scotto d'Abusco. 2014. The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis. Rheumatology International 34: 711–716.CrossRefPubMed Santini, P., L. Politi, P.D. Vedova, R. Scandurra, and A. Scotto d'Abusco. 2014. The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis. Rheumatology International 34: 711–716.CrossRefPubMed
19.
go back to reference Cheng, L., S. Luo, C. Jin, H. Ma, H. Zhou, and L. Jia. 2013. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell Death & Disease 4: e923.CrossRef Cheng, L., S. Luo, C. Jin, H. Ma, H. Zhou, and L. Jia. 2013. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell Death & Disease 4: e923.CrossRef
20.
go back to reference Ma, B., J.L. Simala-Grant, and D.E. Taylor. 2006. Fucosylation in prokaryotes and eukaryotes. Glycobiology 16: 158R–184R.CrossRefPubMed Ma, B., J.L. Simala-Grant, and D.E. Taylor. 2006. Fucosylation in prokaryotes and eukaryotes. Glycobiology 16: 158R–184R.CrossRefPubMed
21.
go back to reference Halloran, M.M., W.W. Carley, P.J. Polverini, C.J. Haskell, S. Phan, B.J. Anderson, J.M. Woods, P.L. Campbell, M.V. Volin, A.E. Backer, et al. 2000. Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. Journal of immunology (Baltimore, Md. : 1950) 164: 4868–4877.CrossRef Halloran, M.M., W.W. Carley, P.J. Polverini, C.J. Haskell, S. Phan, B.J. Anderson, J.M. Woods, P.L. Campbell, M.V. Volin, A.E. Backer, et al. 2000. Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. Journal of immunology (Baltimore, Md. : 1950) 164: 4868–4877.CrossRef
22.
go back to reference Zhu, K., M.A. Amin, M.J. Kim, K.J. Katschke Jr., C.C. Park, and A.E. Koch. 2003. A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. The Journal of Biological Chemistry 278: 21869–21877.CrossRefPubMed Zhu, K., M.A. Amin, M.J. Kim, K.J. Katschke Jr., C.C. Park, and A.E. Koch. 2003. A novel function for a glucose analog of blood group H antigen as a mediator of leukocyte-endothelial adhesion via intracellular adhesion molecule 1. The Journal of Biological Chemistry 278: 21869–21877.CrossRefPubMed
23.
go back to reference Salmon, J.H., A.C. Rat, J. Sellam, M. Michel, J.P. Eschard, F. Guillemin, D. Jolly, and B. Fautrel. 2016. Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies. Osteoarthritis and Cartilage 24: 1500–1508.CrossRefPubMed Salmon, J.H., A.C. Rat, J. Sellam, M. Michel, J.P. Eschard, F. Guillemin, D. Jolly, and B. Fautrel. 2016. Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies. Osteoarthritis and Cartilage 24: 1500–1508.CrossRefPubMed
24.
go back to reference Zhao, L., Y. Qi, L. Xu, X. Tao, X. Han, L. Yin, and J. Peng. 2017. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biology 15: 284–296.CrossRefPubMedPubMedCentral Zhao, L., Y. Qi, L. Xu, X. Tao, X. Han, L. Yin, and J. Peng. 2017. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Redox Biology 15: 284–296.CrossRefPubMedPubMedCentral
25.
go back to reference Zhao, L., L. Liu, Z. Dong, and J. Xiong. 2017. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis. Oncology Reports 38: 3522–3530.PubMed Zhao, L., L. Liu, Z. Dong, and J. Xiong. 2017. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis. Oncology Reports 38: 3522–3530.PubMed
26.
go back to reference Miyaki, S., T. Nakasa, S. Otsuki, S.P. Grogan, R. Higashiyama, A. Inoue, Y. Kato, T. Sato, M.K. Lotz, and H. Asahara. 2009. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis and Rheumatism 60: 2723–2730.CrossRefPubMedPubMedCentral Miyaki, S., T. Nakasa, S. Otsuki, S.P. Grogan, R. Higashiyama, A. Inoue, Y. Kato, T. Sato, M.K. Lotz, and H. Asahara. 2009. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis and Rheumatism 60: 2723–2730.CrossRefPubMedPubMedCentral
27.
go back to reference Diaz-Prado, S., C. Cicione, E. Muinos-Lopez, T. Hermida-Gomez, N. Oreiro, C. Fernandez-Lopez, and F.J. Blanco. 2012. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskeletal Disorders 13: 144.CrossRefPubMedPubMedCentral Diaz-Prado, S., C. Cicione, E. Muinos-Lopez, T. Hermida-Gomez, N. Oreiro, C. Fernandez-Lopez, and F.J. Blanco. 2012. Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskeletal Disorders 13: 144.CrossRefPubMedPubMedCentral
28.
go back to reference Hobert, O. 2008. Gene regulation by transcription factors and microRNAs. Science (New York, N.Y.) 319: 1785–1786.CrossRef Hobert, O. 2008. Gene regulation by transcription factors and microRNAs. Science (New York, N.Y.) 319: 1785–1786.CrossRef
29.
go back to reference Li, Y., Sun, Z., Liu, B., Shan, Y., Zhao, L., and Jia, L. 2017. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. 8, e2892. Li, Y., Sun, Z., Liu, B., Shan, Y., Zhao, L., and Jia, L. 2017. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. 8, e2892.
30.
go back to reference Li, N., Y. Liu, Y. Miao, L. Zhao, H. Zhou, and L. Jia. 2016. MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer. IUBMB Life 68: 764–775.CrossRefPubMed Li, N., Y. Liu, Y. Miao, L. Zhao, H. Zhou, and L. Jia. 2016. MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer. IUBMB Life 68: 764–775.CrossRefPubMed
31.
go back to reference Isozaki, T., J.H. Ruth, M.A. Amin, P.L. Campbell, P.S. Tsou, C.M. Ha, G.K. Haines, G. Edhayan, and A.E. Koch. 2014. Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Research & Therapy 16: R28.CrossRef Isozaki, T., J.H. Ruth, M.A. Amin, P.L. Campbell, P.S. Tsou, C.M. Ha, G.K. Haines, G. Edhayan, and A.E. Koch. 2014. Fucosyltransferase 1 mediates angiogenesis, cell adhesion and rheumatoid arthritis synovial tissue fibroblast proliferation. Arthritis Research & Therapy 16: R28.CrossRef
32.
go back to reference Hu, J., Z. Wang, Y. Pan, J. Ma, X. Miao, X. Qi, H. Zhou, and L. Jia. 2018. MiR-26a and miR-26b mediate osteoarthritis progression by targeting FUT4 via NF-kappaB signaling pathway. The International Journal of Biochemistry & Cell Biology 94: 79–88.CrossRef Hu, J., Z. Wang, Y. Pan, J. Ma, X. Miao, X. Qi, H. Zhou, and L. Jia. 2018. MiR-26a and miR-26b mediate osteoarthritis progression by targeting FUT4 via NF-kappaB signaling pathway. The International Journal of Biochemistry & Cell Biology 94: 79–88.CrossRef
33.
go back to reference Aigner, T., S. Soder, P.M. Gebhard, A. McAlinden, and J. Haag. 2007. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis—structure, chaos and senescence. Nature Clinical Practice. Rheumatology 3: 391–399.CrossRefPubMed Aigner, T., S. Soder, P.M. Gebhard, A. McAlinden, and J. Haag. 2007. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis—structure, chaos and senescence. Nature Clinical Practice. Rheumatology 3: 391–399.CrossRefPubMed
34.
go back to reference Li, X., Z. Zhen, G. Tang, C. Zheng, and G. Yang. 2016. MiR-29a and MiR-140 protect chondrocytes against the anti-proliferation and cell matrix signaling changes by IL-1beta. Molecules and Cells 39: 103–110.CrossRefPubMed Li, X., Z. Zhen, G. Tang, C. Zheng, and G. Yang. 2016. MiR-29a and MiR-140 protect chondrocytes against the anti-proliferation and cell matrix signaling changes by IL-1beta. Molecules and Cells 39: 103–110.CrossRefPubMed
35.
go back to reference Li, H., S.B. Guan, Y. Lu, and F. Wang. 2017. MiR-140-5p inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion through targeting TLR4. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 96: 208–214.CrossRef Li, H., S.B. Guan, Y. Lu, and F. Wang. 2017. MiR-140-5p inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion through targeting TLR4. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 96: 208–214.CrossRef
36.
go back to reference Yang, D., G. Du, A. Xu, X. Xi, and D. Li. 2017. Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4. American Journal of Cancer Research 7: 2209–2219.PubMedPubMedCentral Yang, D., G. Du, A. Xu, X. Xi, and D. Li. 2017. Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4. American Journal of Cancer Research 7: 2209–2219.PubMedPubMedCentral
37.
go back to reference Musumeci, G., C. Loreto, M.L. Carnazza, and G. Martinez. 2011. Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 19: 307–313.CrossRef Musumeci, G., C. Loreto, M.L. Carnazza, and G. Martinez. 2011. Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 19: 307–313.CrossRef
38.
go back to reference Johnson, E.O., A. Charchandi, G.C. Babis, and P.N. Soucacos. 2008. Apoptosis in osteoarthritis: morphology, mechanisms, and potential means for therapeutic intervention. Journal of Surgical Orthopaedic Advances 17: 147–152.PubMed Johnson, E.O., A. Charchandi, G.C. Babis, and P.N. Soucacos. 2008. Apoptosis in osteoarthritis: morphology, mechanisms, and potential means for therapeutic intervention. Journal of Surgical Orthopaedic Advances 17: 147–152.PubMed
39.
go back to reference Rockel, J.S., and M. Kapoor. 2016. Autophagy: controlling cell fate in rheumatic diseases. Nature reviews. Rheumatology 12: 517–531.CrossRefPubMed Rockel, J.S., and M. Kapoor. 2016. Autophagy: controlling cell fate in rheumatic diseases. Nature reviews. Rheumatology 12: 517–531.CrossRefPubMed
40.
go back to reference Meng, Y., R. Gao, J. Ma, J. Zhao, E. Xu, C. Wang, and X. Zhou. 2017. MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy. Scientific Reports 7: 416.CrossRefPubMedPubMedCentral Meng, Y., R. Gao, J. Ma, J. Zhao, E. Xu, C. Wang, and X. Zhou. 2017. MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy. Scientific Reports 7: 416.CrossRefPubMedPubMedCentral
41.
go back to reference Wei, R., G. Cao, Z. Deng, J. Su, and L. Cai. 2016. miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells. Bioscience Reports 36. Wei, R., G. Cao, Z. Deng, J. Su, and L. Cai. 2016. miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells. Bioscience Reports 36.
Metadata
Title
miR-140-5p/miR-149 Affects Chondrocyte Proliferation, Apoptosis, and Autophagy by Targeting FUT1 in Osteoarthritis
Authors
Zi Wang
Jialei Hu
Yue Pan
Yujia Shan
Liqun Jiang
Xia Qi
Li Jia
Publication date
01-06-2018
Publisher
Springer US
Published in
Inflammation / Issue 3/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0750-6

Other articles of this Issue 3/2018

Inflammation 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.